U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Spasm of cerebral arteries

MedGen UID:
78532
•Concept ID:
C0265110
•
Disease or Syndrome
Synonyms: Angiospasm, Cerebral; Angiospasms, Cerebral; Artery Spasm, Cerebral; Artery Spasms, Cerebral; Cerebral Angiospasm; Cerebral Angiospasms; Cerebral Artery Spasm; Cerebral Artery Spasms; Cerebral Vasospasm; Cerebral Vasospasms; Cerebrovascular Spasm; Cerebrovascular Spasms; Spasm, Cerebral Artery; Spasm, Cerebrovascular; Spasms, Cerebral Artery; Spasms, Cerebrovascular; Vasospasm, Cerebral; Vasospasms, Cerebral
SNOMED CT: Spasm of cerebral arteries (73173006); Cerebral arterial spasm (73173006)

Professional guidelines

PubMed

Treatment of the traumatic cerebral vasospasm with the calciumchannel blocker nimodipine: a preliminary report.
Kostron H, Twerdy K, Stampfl G, Mohsenipour I, Fischer J, Grunert V
Neurol Res 1984 Mar-Jun;6(1-2):29-32. doi: 10.1080/01616412.1984.11739660. PMID: 6147775

Recent clinical studies

Etiology

Haemodynamic effectiveness of nimodipine on spastic brain vessels after subarachnoid haemorrhage evaluated by the transcranial Doppler method. A review of clinical studies.
Harders A, Gilsbach J
Acta Neurochir Suppl (Wien) 1988;45:21-8. doi: 10.1007/978-3-7091-9014-2_4. PMID: 3066139

Diagnosis

The novel and specific Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]-homopiperazine as a probing molecule for Rho-kinase-involved pathway.
Sasaki Y, Suzuki M, Hidaka H
Pharmacol Ther 2002 Feb-Mar;93(2-3):225-32. doi: 10.1016/s0163-7258(02)00191-2. PMID: 12191614
Recent insights into the regulation of cerebral circulation.
Brian JE Jr, Faraci FM, Heistad DD
Clin Exp Pharmacol Physiol 1996 Jun-Jul;23(6-7):449-57. doi: 10.1111/j.1440-1681.1996.tb02760.x. PMID: 8800565
Provocation of coronary spasm by dopamine in patients with active variant angina pectoris.
Crea F, Chierchia S, Kaski JC, Davies GJ, Margonato A, Miran DO, Maseri A
Circulation 1986 Aug;74(2):262-9. doi: 10.1161/01.cir.74.2.262. PMID: 3731418

Therapy

Use of levosimendan in the treatment of cerebral vascular vasospasm: a case study.
Onichimowski D, Nosek K, Goraj R, Jalali R, Wińska A, Pawlos A, Tuyakov B
Drug Des Devel Ther 2018;12:1777-1783. Epub 2018 Jun 20 doi: 10.2147/DDDT.S158237. PMID: 29950812Free PMC Article
The novel and specific Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]-homopiperazine as a probing molecule for Rho-kinase-involved pathway.
Sasaki Y, Suzuki M, Hidaka H
Pharmacol Ther 2002 Feb-Mar;93(2-3):225-32. doi: 10.1016/s0163-7258(02)00191-2. PMID: 12191614
Haemodynamic effectiveness of nimodipine on spastic brain vessels after subarachnoid haemorrhage evaluated by the transcranial Doppler method. A review of clinical studies.
Harders A, Gilsbach J
Acta Neurochir Suppl (Wien) 1988;45:21-8. doi: 10.1007/978-3-7091-9014-2_4. PMID: 3066139
Treatment of the traumatic cerebral vasospasm with the calciumchannel blocker nimodipine: a preliminary report.
Kostron H, Twerdy K, Stampfl G, Mohsenipour I, Fischer J, Grunert V
Neurol Res 1984 Mar-Jun;6(1-2):29-32. doi: 10.1080/01616412.1984.11739660. PMID: 6147775

Prognosis

Use of levosimendan in the treatment of cerebral vascular vasospasm: a case study.
Onichimowski D, Nosek K, Goraj R, Jalali R, Wińska A, Pawlos A, Tuyakov B
Drug Des Devel Ther 2018;12:1777-1783. Epub 2018 Jun 20 doi: 10.2147/DDDT.S158237. PMID: 29950812Free PMC Article
The novel and specific Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]-homopiperazine as a probing molecule for Rho-kinase-involved pathway.
Sasaki Y, Suzuki M, Hidaka H
Pharmacol Ther 2002 Feb-Mar;93(2-3):225-32. doi: 10.1016/s0163-7258(02)00191-2. PMID: 12191614
Treatment of the traumatic cerebral vasospasm with the calciumchannel blocker nimodipine: a preliminary report.
Kostron H, Twerdy K, Stampfl G, Mohsenipour I, Fischer J, Grunert V
Neurol Res 1984 Mar-Jun;6(1-2):29-32. doi: 10.1080/01616412.1984.11739660. PMID: 6147775

Clinical prediction guides

The novel and specific Rho-kinase inhibitor (S)-(+)-2-methyl-1-[(4-methyl-5-isoquinoline)sulfonyl]-homopiperazine as a probing molecule for Rho-kinase-involved pathway.
Sasaki Y, Suzuki M, Hidaka H
Pharmacol Ther 2002 Feb-Mar;93(2-3):225-32. doi: 10.1016/s0163-7258(02)00191-2. PMID: 12191614
Treatment of the traumatic cerebral vasospasm with the calciumchannel blocker nimodipine: a preliminary report.
Kostron H, Twerdy K, Stampfl G, Mohsenipour I, Fischer J, Grunert V
Neurol Res 1984 Mar-Jun;6(1-2):29-32. doi: 10.1080/01616412.1984.11739660. PMID: 6147775

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • MeSH
      Related Medical Subject Headings
    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...